Key Points
            - Stabilize ABCs; treat life‑threatening derangements immediately.
- Confirm diagnosis early with highest‑yield imaging/labs.
- Initiate guideline‑based therapy and escalate by response.
- Plan disposition and follow‑up explicitly.
                                        Clinical Synopsis & Reasoning
            HHS presents with profound hyperglycemia, hyperosmolality (>320 mOsm/kg), and minimal ketosis. Initial 0.9% saline restores volume; transition to 0.45% saline guided by corrected sodium and osmolality. Start regular insulin 0.05–0.1 U/kg/h only after initial fluids; avoid rapid osmolality shifts. Replace potassium to maintain 4.0–5.0 mEq/L; add dextrose when glucose <300 mg/dL.
                                        Treatment Strategy & Disposition
            HHS presents with profound hyperglycemia, hyperosmolality (>320 mOsm/kg), and minimal ketosis. Initial 0.9% saline restores volume; transition to 0.45% saline guided by corrected sodium and osmolality. Start regular insulin 0.05–0.1 U/kg/h only after initial fluids; avoid rapid osmolality shifts. Replace potassium to maintain 4.0–5.0 mEq/L; add dextrose when glucose <300 mg/dL.
                                        Epidemiology / Risk Factors
            - Risk varies by comorbidity and precipitating factors
                                        Initial Targets
            
              
                | Parameter | Target/Action | 
|---|
                
                  | Hemodynamics | Maintain perfusion; avoid hypotension | 
| Monitoring | Serial exam, labs, and imaging | 
| Therapy | Start early, reassess, de‑escalate when appropriate | 
                
              
             
                                        Investigations
            
              
                | Test | Role / Rationale | Typical Findings | Notes | 
|---|
                
                  | CBC | Screen leukocytosis/anemia | Context‑specific | Trend response | 
| BMP | Electrolytes/renal function | Derangements common | Replace K+/Mg2+ | 
| Key imaging | Condition‑specific (CTA/MRI/Endoscopy) | See text | Do not delay when red flags | 
                
              
             
                                        Pharmacology
            
              
                | Medication | Mechanism | Onset | Role in Therapy | Limitations | 
|---|
                
                  | 0.9% Saline then 0.45% | Crystalloid | Immediate | Restore volume/correct osmolality | Switch to D5 when glucose <300 | 
| Regular insulin infusion | Insulin | Minutes | Lower glucose/osmolality | Start after fluids; 0.05–0.1 U/kg/h | 
| Potassium chloride | Electrolyte | Immediate | Prevent arrhythmia | Replace to 4–5 mEq/L | 
                
              
             
                                        Prognosis / Complications
            - Outcome depends on timeliness of diagnosis and definitive therapy
                                        Patient Education / Counseling
            - Explain red flags, adherence, and follow‑up plan
                  
        
                  References
                      - ADA/Consensus Report on Hyperglycemic Crises (2024) — Link
- Cleveland Clinic J Med summary (2025) — Link